Effect of rumen-protected L-tryptophan on productivity and metabolic responses in dry Holstein cows under heat stress conditions Authors: Jang Hoon Jo, Jalil Ghassemi Nejad, Moon Jun Ok, Hong Gu Lee Published: 2026 ABSTRACT This study aimed to investigate the potential effects of L-tryptophan on the productivity, physiological indicators, blood hematology, metabolite and free amino acid concentrations, gene expression in peripheral blood mononuclear cells, and metabolomics of dry Holstein cows under heat stress conditions. The study involved eight dry Holstein cows, with four cows per experiment, and was carried out in environmentally controlled metabolic chambers. Each experiment involved treatment using two heat stress conditions: low-temperature and low-humidity (LTLH) conditions (25 °C, 35%), and high-temperature and high-humidity (HTHH) conditions (31 °C, 80%). The cows were exposed to LTLH and HTHH conditions for 3 days during the adaptation phase, followed by 4 days of heat stress, and then 7 days of heat stress with rumen-protected L-tryptophan supplementation (ACT). In the study, dry matter intake increased, but rectal and skin temperature decreased in the HTHH group. Blood urea nitrogen and non-esterified fatty acid decreased, while glucose and ghrelin increased in the HTHH group. DL-plus allo-δ-Hydroxylysine increased in the HTHH group. In the HTHH group, the supplementation ACT resulted in increased gene expression of heat shock protein 70 in peripheral blood mononuclear cells. The blood metabolomic analysis also identified a distinct tendency in the HTHH group. These results suggest that supplementation with rumen-protected L-tryptophan improved the productivity, physiological indicators, blood parameters, and gene expression in the peripheral blood mononuclear cells of dry Holstein cows under high-temperature–humidity conditions. Overall, the L-tryptophan and acetate in ACT may alleviate stress in dry Holstein cows exposed to heat stress and has potential as an anti-stress supplement. Introduction The issue of environmental change has attracted the interest of international academics and the dairy industry over the past decade, with reports indicating that hot summer environments will occur frequently around the world1. Climatic data from 1998 to 2018 indicate that South Korea experiences a summer mean temperature of approximately 25.29 °C, with relative humidity (RH) averaging around 78.10%. Regional surveys further report summer temperatures ranging from 22 to 25 °C and RH levels between 70 and 95%2. During heat stress (HS), blood flow is redirected to the skin to enhance heat loss, which may impair digestion and increase susceptibility to inflammation and infection3. Heat stress (HS) alters nutrient partitioning, leading to elevated glucose (GLU), blood urea nitrogen (BUN), and reduced free amino acids, indicating increased whole-body amino acid catabolism and disrupted nitrogen metabolism4–6. The dry period is a critical phase in dairy production, during which 60% of fetal growth occurs and metabolic adaptations prepare dry Holstein cows for parturition and lactation7. Effective management during this phase improves health, tissue recovery, and resistance to disease. However, dry Holstein cows are often insufficiently monitored during this period, increasing the risk of impaired metabolic function, poor performance, and negative epigenetic effects. Heat stress (HS) during the dry period further exacerbates these issues by reducing dry matter intake (DMI), disrupting energy balance, and ultimately compromising productivity7. Nutritional strategies that improve DMI and metabolic stability during this phase are essential for minimizing HS-related losses8. Various nutritional strategies have been explored to mitigate alterations in feed utilization and prevent reductions in productivity9,10. Rumen-protected L-tryptophan supplementation (ACT) has been shown to enhance intestinal barrier function in ruminants and mitigate the hyperpermeability effects of dietary restriction, improving inflammation and intestinal health in Hanwoo steers11. Additionally, ACT supplementation improved milk production and protein content in lactating Holstein cows under HS12,13. In general, HS are some conditions that may affect L-tryptophan requirements and metabolism during gestation. L-tryptophan degradation plays an immunoregulatory role during pregnancy, which is vital for maternal–fetal immune tolerance14. However, the requirement for L-tryptophan for fetal protein synthesis suddenly increases, while DMI decreases during the dry period. Upon exposure to HS, metabolite profiling of the blood of dairy cows revealed a consistent decline in L-tryptophan levels with increased heat intensity12. Moreover, it was ascertained that metabolic pathways associated with L-tryptophan, such as phenylalanine, tyrosine, and tryptophan biosynthesis, underwent alterations under HS conditions15,16. Given this phenomenon, L-tryptophan should be supplemented in the det of dry Holstein cows under HS conditions to evaluate not only its direct effects but also its potential benefit under thermal challenges. However, the extent to which L-tryptophan supplementation is effective during HS to yield desirable effects, remain not fully understood. Therefore, the purpose of this study was to confirm the effectiveness of rumen-protected L-tryptophan supplementation through changes in DMI, blood hematology, metabolites, free amino acid, and gene expression in peripheral blood mononuclear cells (PBMCs) in climate chambers under HS conditions (Tables 1 and 2).Table 1Analyses of chemical compositions and amino acid profile of experimental feed.Parameters1StrawConcentratesIngredients, % (dry matter basis) Corn gluten feed7.81 Molasses4.34 Palm kernel meal8.85 Soybean meal13.02 Corn21.70 Wheat1.30 Molasses4.34 Wheat bran9.55 Rapeseed meal4.34 Corn gluten meal0.87 Coconut meal5.21 Palm Kernel meal8.81 Corn germ meal1.74 Sesame seed meal0.87 Distillers dried grains with soluble4.34 Salt0.87 Limestone1.30 Sodium bicarbonate0.43 MgO0.17 Vitamin mineral premix2, IU/kg0.13Analyzed values (%, dry matter basis) Dry matter82.7588.96 Crude protein3.4220.33 Crude fat1.033.10 Crude fiber20.317.25 Crude ash6.66.94 Calcium0.260.69 Phosphorus0.120.56 NDF40.1824.33 NDIP4.053.17 NDFn36.1321.16 ADF26.9412.05 ADIP1.250.82Estimated values3 NFC48.7745.30 tdNFC53.8349.40 tdCP2.2119.37 tdFA0.032.10Amino acids, % (DM) Tryptophan0.030.04 Threonine0.120.41 Serine0.140.52 Proline0.200.81 Valine0.140.61 Isoleucine0.100.39 Leucine0.180.93 Tyrosine0.050.30 Methionine0.050.20 Cystine0.080.31 Lysine0.150.42 Glycine0.140.55 Alanine0.200.64 Arginine0.120.89 Glutamic acid0.382.16 Aspartic acid0.240.86 Histidine0.060.29 Phenylalanine0.100.51DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. 1NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; NDFn, NDF-NDIP; ADF, acid detergent fiber; ADIP, acid detergent insoluble crude protein;2Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg.DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. a Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6,250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg.3The estimated values were calculated according to the NRC (2001). NFC, nonfibrous carbohydrate; tdNFC, truly digestible nonfibrous carbohydrate; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid.Table 2Bovine primer sequence design.GeneAccession Number1Sequence (5′ to 3′)Length (bp)Annealing temperature, °CHSP70U09861F: TACGTGGCCTTCACCGATACR: GTCGTTGATGACGCGGAAAG17160.7GAPDHNM_001034034.2F: GGCAAGGTCATCCCTGAGR: GCAGGTCAGATCCACAACAG16657.9B2MNM_173893.3F: GACACCCACCAGAAGATGGAR: CAGGTCTGACTGCTCCGATT12561RPS15ANM_001037443.2F: CCGTGCTCCAAAGTCATCGTR: GGGAGCAGGTTATTCTGCCA20061HSP70, heat shock protein 70; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; B2M, beta-2-macroglobulin; RPS15A, ribosomal protein S15a.1Database protein names and accession number: NCBI (http://www.ncbi.nih/gov). Table 1Analyses of chemical compositions and amino acid profile of experimental feed.Parameters1StrawConcentratesIngredients, % (dry matter basis) Corn gluten feed7.81 Molasses4.34 Palm kernel meal8.85 Soybean meal13.02 Corn21.70 Wheat1.30 Molasses4.34 Wheat bran9.55 Rapeseed meal4.34 Corn gluten meal0.87 Coconut meal5.21 Palm Kernel meal8.81 Corn germ meal1.74 Sesame seed meal0.87 Distillers dried grains with soluble4.34 Salt0.87 Limestone1.30 Sodium bicarbonate0.43 MgO0.17 Vitamin mineral premix2, IU/kg0.13Analyzed values (%, dry matter basis) Dry matter82.7588.96 Crude protein3.4220.33 Crude fat1.033.10 Crude fiber20.317.25 Crude ash6.66.94 Calcium0.260.69 Phosphorus0.120.56 NDF40.1824.33 NDIP4.053.17 NDFn36.1321.16 ADF26.9412.05 ADIP1.250.82Estimated values3 NFC48.7745.30 tdNFC53.8349.40 tdCP2.2119.37 tdFA0.032.10Amino acids, % (DM) Tryptophan0.030.04 Threonine0.120.41 Serine0.140.52 Proline0.200.81 Valine0.140.61 Isoleucine0.100.39 Leucine0.180.93 Tyrosine0.050.30 Methionine0.050.20 Cystine0.080.31 Lysine0.150.42 Glycine0.140.55 Alanine0.200.64 Arginine0.120.89 Glutamic acid0.382.16 Aspartic acid0.240.86 Histidine0.060.29 Phenylalanine0.100.51DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. 1NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; NDFn, NDF-NDIP; ADF, acid detergent fiber; ADIP, acid detergent insoluble crude protein;2Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg.DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. a Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6,250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg.3The estimated values were calculated according to the NRC (2001). NFC, nonfibrous carbohydrate; tdNFC, truly digestible nonfibrous carbohydrate; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. Analyses of chemical compositions and amino acid profile of experimental feed. DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. 1NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; NDFn, NDF-NDIP; ADF, acid detergent fiber; ADIP, acid detergent insoluble crude protein; 2Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg. DM, dry matter; ADF, acid detergent fiber; NDF, neutral detergent fiber; NDIP, neutral detergent insoluble crude protein; ADIP, acid detergent insoluble crude protein; tdNFC, truly digestible NFC; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. a Vitamin mineral premix: Vit. A 1,000,000 IU; Vit. D3 100,000 IU ; Vit E 25,000 mg ; I 150 mg; Co 150 mg; Cu 2500 mg; Fe 6,250 mg; Mn 16,000 mg; Zn 10,000 mg; Se 150 mg. 3The estimated values were calculated according to the NRC (2001). NFC, nonfibrous carbohydrate; tdNFC, truly digestible nonfibrous carbohydrate; tdCP, truly digestible crude protein; tdFA, truly digestible fatty acid. Table 2Bovine primer sequence design.GeneAccession Number1Sequence (5′ to 3′)Length (bp)Annealing temperature, °CHSP70U09861F: TACGTGGCCTTCACCGATACR: GTCGTTGATGACGCGGAAAG17160.7GAPDHNM_001034034.2F: GGCAAGGTCATCCCTGAGR: GCAGGTCAGATCCACAACAG16657.9B2MNM_173893.3F: GACACCCACCAGAAGATGGAR: CAGGTCTGACTGCTCCGATT12561RPS15ANM_001037443.2F: CCGTGCTCCAAAGTCATCGTR: GGGAGCAGGTTATTCTGCCA20061HSP70, heat shock protein 70; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; B2M, beta-2-macroglobulin; RPS15A, ribosomal protein S15a.1Database protein names and accession number: NCBI (http://www.ncbi.nih/gov). Bovine primer sequence design. F: TACGTGGCCTTCACCGATAC R: GTCGTTGATGACGCGGAAAG F: GGCAAGGTCATCCCTGAG R: GCAGGTCAGATCCACAACAG F: GACACCCACCAGAAGATGGA R: CAGGTCTGACTGCTCCGATT F: CCGTGCTCCAAAGTCATCGT R: GGGAGCAGGTTATTCTGCCA HSP70, heat shock protein 70; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; B2M, beta-2-macroglobulin; RPS15A, ribosomal protein S15a. 1Database protein names and accession number: NCBI (http://www.ncbi.nih/gov). Results Dry matter intake and water intake This study measured DMI under HS and with the supplementation of ACT (Table 3). Significant differences were observed between HS and ACT factors (P < 0.05). In the LTLH group, DMI increased by 5.36% under HS and further increased by 5.44% with ACT supplementation. However, in the HTHH group, DMI decreased by 14.71% under HS but increased by 12.25% with ACT supplementation. Water intake increased by 9.89% in the LTLH group and 23.80% in the HTHH group during HS (P < 0.05). Under HS the DMI-to-water intake ratio decreased by 3.78% in LTLH group and 42.28% in HTHH group. Under HS, the ratio increased by 0.91% in LTLH group and 36.57% in HTHH group with ACT supplementation (P < 0.05).Table 3Relationship between rumen-protected L-tryptophan (ACT) and intake under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTDMI, kg/day10.8211.3912.029.858.419.760.2780.0010.0490.229WI, L/day45.6050.1150.7546.3457.3752.941.0570.0010.2020.922DMI:WI0.250.240.240.230.140.180.0070.0010.0010.167Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error mean; DMI, dry matter intake; WI, water intake. Table 3Relationship between rumen-protected L-tryptophan (ACT) and intake under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTDMI, kg/day10.8211.3912.029.858.419.760.2780.0010.0490.229WI, L/day45.6050.1150.7546.3457.3752.941.0570.0010.2020.922DMI:WI0.250.240.240.230.140.180.0070.0010.0010.167Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error mean; DMI, dry matter intake; WI, water intake. Relationship between rumen-protected L-tryptophan (ACT) and intake under heat stress (HS) conditions in dry Holstein cows. Values are expressed as means ± SEM (n = 4). LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error mean; DMI, dry matter intake; WI, water intake. Physiological indicators This study evaluated key physiological indicators in dairy cows, including dry Holstein cows, under HS (Table 4). A significant difference was found in heart rate (HR) for the HS factor (P < 0.05), while a statistical trend was observed for the ACT supplementation (P = 0.067).Table 4Relationship between rumen-protected L-tryptophan (ACT) and physiological indicators under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTHeart rate, beat/min73.0073.2573.3374.0090.7584.751.5640.0010.0670.060Rectal temperature, ℃38.1038.4838.3338.0038.7838.430.0640.0010.0010.123Skin temperature, ℃28.0828.7828.4028.2034.5333.700.5880.0010.0130.295Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean. Table 4Relationship between rumen-protected L-tryptophan (ACT) and physiological indicators under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTHeart rate, beat/min73.0073.2573.3374.0090.7584.751.5640.0010.0670.060Rectal temperature, ℃38.1038.4838.3338.0038.7838.430.0640.0010.0010.123Skin temperature, ℃28.0828.7828.4028.2034.5333.700.5880.0010.0130.295Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean. Relationship between rumen-protected L-tryptophan (ACT) and physiological indicators under heat stress (HS) conditions in dry Holstein cows. Values are expressed as means ± SEM (n = 4). LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean. Significant differences were observed in rectal temperature (RT) for both HS and ACT factors (P < 0.05). Specifically, both the LTLH and HTHH groups showed increases of 1% and 2.05% under HS, but decreases of 0.39% and 0.90% with ACT supplementation, respectively. Similarly, skin temperature (ST) showed significant differences for both HS and ACT factors (P < 0.05). In the LTLH and HTHH groups, ST increased by 2.49% and 22.45% under HS, but decreased by 1.32% and 2.40% with ACT supplementation, respectively. A tendency for HS x ACT interaction was present for HR (P = 0.060). Blood metabolite and hormone The effects of ACT supplementation on blood metabolites and hormones were examined in dry Holstein cows under HS (Table 5). For BUN, HS resulted in a 4.76% increase in the LTLH group and a 29.63% increase in the HTHH group (P < 0.05). With ACT supplementation, BUN decreased by 4.55% in the LTLH group and 22.86% in the HTHH group (P < 0.05). For GLU, under HS, the LTLH group showed a 0.37% increase, while the HTHH group showed a 19.54%decrease (P < 0.05). After ACT supplementation, both groups exhibited increase of 1.49% and 13.33%, respectively (P < 0.05). Regarding ghrelin, HS led to a 5.93% decrease in the LTLH group and a 33.14% decrease in the HTHH group (P < 0.05). ACT supplementation tendency increased ghrelin in the LTLH group and in the HTHH group (P = 0.050). For cortisol, HS caused a 21.44% increase in the LTLH group and a 150.16% increase in the HTHH group (P < 0.05). In non-esterified fatty acid (NEFA), ACT supplementation decreased concentrations by 57.74% and 32.25%, respectively (P < 0.05). For calcium indicators, HS caused a tendency for a decrease in the LTLH group and in the HTHH group (P = 0.098). In cholesterol (CHO), ACT supplementation under HS showed a tendency for a decrease in the LTLH group and in the HTHH group (P = 0.091).Table 5Relationship between rumen-protected L-tryptophan (ACT) and blood metabolites and hormones under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTAlbumin, g/dL3.603.513.523.633.523.540.0240.4100.6280.861BUN, mg/dL5.255.505.255.678.756.750.3320.0010.0450.1056CA, mg/dL10.209.989.9310.309.639.850.0800.0980.6390.497CHO, mg/dL194.25177.00146.50200.25180.25153.256.9150.6710.0910.881r-Globulin, g/dL4.144.094.153.833.723.780.0940.2630.5760.741GLU, mg/dL66.7567.0068.0065.2552.5059.501.3140.0010.0130.230GOT, U/L105.0096.5084.0082.0074.5075.5010.5420.8260.9930.980r-GT, U/L25.5025.2528.0027.7527.2527.001.9080.9900.6670.636MG, mg/dL2.032.152.232.202.282.200.0360.3600.1750.227NEFA, uEq/L195.75227.7596.25166.25224.00151.7512.9190.2050.0010.238IP, mg/dL5.335.185.256.136.286.030.1960.2160.8270.790TP, g/dL7.747.607.677.477.247.310.1040.3160.5380.735Cortisol, ng/mL30.0436.4833.1831.3278.3564.255.3240.0020.3900.605Haptoglobin, ng/mL33.1936.1335.7033.9464.7261.732.9990.0010.4920.605Ghrelin, pg/mL182.39171.57189.98179.88120.27153.296.7360.0010.0500.564Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; BUN, blood urea nitrogen; CA, calcium; CHO, cholesterol; GLU, glucose; GOT, glutamic-oxaloacetic transaminase; r-GT, gamma-glutamyltranspeptidase; MG, magnesium; NEFA, non-esterified fatty acid; IP, inorganic phosphorous; TP, total protein. Table 5Relationship between rumen-protected L-tryptophan (ACT) and blood metabolites and hormones under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTAlbumin, g/dL3.603.513.523.633.523.540.0240.4100.6280.861BUN, mg/dL5.255.505.255.678.756.750.3320.0010.0450.1056CA, mg/dL10.209.989.9310.309.639.850.0800.0980.6390.497CHO, mg/dL194.25177.00146.50200.25180.25153.256.9150.6710.0910.881r-Globulin, g/dL4.144.094.153.833.723.780.0940.2630.5760.741GLU, mg/dL66.7567.0068.0065.2552.5059.501.3140.0010.0130.230GOT, U/L105.0096.5084.0082.0074.5075.5010.5420.8260.9930.980r-GT, U/L25.5025.2528.0027.7527.2527.001.9080.9900.6670.636MG, mg/dL2.032.152.232.202.282.200.0360.3600.1750.227NEFA, uEq/L195.75227.7596.25166.25224.00151.7512.9190.2050.0010.238IP, mg/dL5.335.185.256.136.286.030.1960.2160.8270.790TP, g/dL7.747.607.677.477.247.310.1040.3160.5380.735Cortisol, ng/mL30.0436.4833.1831.3278.3564.255.3240.0020.3900.605Haptoglobin, ng/mL33.1936.1335.7033.9464.7261.732.9990.0010.4920.605Ghrelin, pg/mL182.39171.57189.98179.88120.27153.296.7360.0010.0500.564Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; BUN, blood urea nitrogen; CA, calcium; CHO, cholesterol; GLU, glucose; GOT, glutamic-oxaloacetic transaminase; r-GT, gamma-glutamyltranspeptidase; MG, magnesium; NEFA, non-esterified fatty acid; IP, inorganic phosphorous; TP, total protein. Relationship between rumen-protected L-tryptophan (ACT) and blood metabolites and hormones under heat stress (HS) conditions in dry Holstein cows. Values are expressed as means ± SEM (n = 4). LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; BUN, blood urea nitrogen; CA, calcium; CHO, cholesterol; GLU, glucose; GOT, glutamic-oxaloacetic transaminase; r-GT, gamma-glutamyltranspeptidase; MG, magnesium; NEFA, non-esterified fatty acid; IP, inorganic phosphorous; TP, total protein. Serum free amino acid The effects of ACT supplementation on blood free amino acids in dry Holstein cows under HS were investigated (Table 6). DL-plus-allo-δ-Hydroxylysine increased in both the LTLH and HTHH groups (3.30% and 8.70%, respectively) when ACT was added under HS conditions (P < 0.05). o-phosphoserine tended to decrease in both the LTLH and HTHH groups with ACT supplementation under HS (P = 0.065). Taurine decreased by 2.13% in the LTLH group but increased by 39.72% in the HTHH group under HS (P < 0.05). After ACT supplementation, taurine tended to decrease in the LTLH group and in the HTHH group (P = 0.082). L-threonine decreased in LTLH group and showed a trend of decrease in HTHH group with ACT supplementation under HS (P = 0.093). L-alanine decreased by 11.93% in the LTLH group but increased by 19.40% in the HTHH group under HS (P < 0.05). DL-2-aminobutyric acid decreased by 3.01% in the LTLH group and by 12.91% in the HTHH group under HS (P < 0.05). L-isoleucine decreased by 29.67% in LTLH group but increased by 58.67% in HTHH group under HS (P < 0.05). DL-3-aminoisobutyric acid decreased by 12.50% in the LTLH group but increased by 29.63% in the HTHH group under HS (P < 0.05). Ammonium chloride decreased in both the LTLH and HTHH groups under HS by 48.94% and 21.71%, respectively (P < 0.05). A tendency for an HS x ACT interaction was present for L-leucine (P = 0.089) (Fig. 1).Table 6Relationship between rumen-protected L-tryptophan (ACT) and blood amino acids (AAs) under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTo-Phosphoserine, ug/mL6.777.142.57 7.29 7.84 6.050.4120.2300.0650.214Taurine, ug/mL4.224.132.88 5.06 7.07 4.920.3380.0270.0820.460L-Aspartic acid, ug/mL0.660.590.55 0.61 0.57 0.580.0150.3680.7670.549L-Threonine, ug/mL6.836.655.75 7.36 6.84 6.190.1900.6030.0930.775L-Serine, ug/mL6.936.426.43 6.76 6.31 6.770.1710.7460.6140.620L-Glutamic acid, ug/mL13.3410.5610.55 9.0812.2011.100.5950.2190.7070.713L-2-Aminoadipic Acid, ug/mL1.792.022.09 1.98 2.21 2.410.1050.6090.6240.826L-Alanine, ug/mL25.0722.0822.7025.4730.4132.340.9510.0010.3950.657L-Citrulline, ug/mL41.6236.4837.8437.6331.9932.721.3340.1520.7460.922DL-2-Aminobutyric acid, ug/mL6.646.446.28 8.75 7.62 7.870.2600.0050.9280.689L-Valine, ug/mL3.664.043.32 3.88 3.62 3.850.1780.9880.6100.336L-Cysteine, ug/mL50.3852.1148.5547.2350.9749.721.2940.7920.4950.743L-Cystathionine, ug/mL2.562.652.42 2.87 2.81 2.970.1130.5800.9120.514L-Isoleucine, ug/mL0.910.640.67 0.75 1.19 2.030.1450.0300.1520.177L-Leucine, ug/mL11.6212.8110.9312.0411.5112.790.3490.9490.7400.089L-Tyrosine, ug/mL21.4621.7919.7223.7322.8722.550.5490.3340.3810.521L-Phenylalanine, ug/mL7.587.877.53 7.39 7.03 8.440.2850.9980.4870.257β-Alanine, ug/mL4.764.304.02 4.96 4.65 4.920.1500.2740.9920.459DL-3-Aminoisobutyric Acid, ug/mL0.240.210.21 0.27 0.35 0.290.0140.0020.2550.2792-Aminoethanol, ug/mL0.040.020.03 0.00 0.05 0.070.0080.1350.5800.811Ammonium Chlodire, ug/mL1.412.102.06 1.29 1.57 1.410.0990.0120.6360.748DL-plus allo-δ-Hydroxylysine, ug/mL2.292.122.19 2.11 2.07 2.250.0270.0710.0460.348L-Ornithine, ug/mL6.297.015.93 6.70 5.87 6.450.2330.9180.6830.183Lysine, ug/mL8.8410.858.38 9.86 8.97 8.980.3470.6300.1590.156L-1-Methylhistidine, ug/mL1.141.821.77 1.66 1.97 2.230.1980.6260.8490.765L-3-Methylhistidine, ug/mL1.221.071.02 1.27 1.29 1.250.0720.6960.8200.977L-Carnosine, ug/mL1.251.461.91 1.18 1.60 2.430.1760.7550.1450.653Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean.Fig. 1Experimental (a) design and (b) period. The schematic delineates the experimental design executed within climate chambers, emphasizing heat stress (HS) treatments, specifically low-temperature, low-humidity (LTLH) and high-temperature, high-humidity (HTHH) conditions, supplemented with rumen-protected L-tryptophan (ACT) interventions. Eight early lactating Holstein cows were stratified and subsequently randomized into two groups. In the initial non-HS phase, the cows were subjected to a temperature–humidity index (THI) of 68 over a three-day period. Following this, a designated treatment was administered for four days. Subsequently, a seven-day phase was initiated, during which the cows were exposed to the predefined HS in tandem with ACT administration. After the LTLH treatment was completed, the HTHH treatment was carried out employing a comparable methodology but involving a distinct group of dry Holstein cows. THI: temperature–humidity index. Table 6Relationship between rumen-protected L-tryptophan (ACT) and blood amino acids (AAs) under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTo-Phosphoserine, ug/mL6.777.142.57 7.29 7.84 6.050.4120.2300.0650.214Taurine, ug/mL4.224.132.88 5.06 7.07 4.920.3380.0270.0820.460L-Aspartic acid, ug/mL0.660.590.55 0.61 0.57 0.580.0150.3680.7670.549L-Threonine, ug/mL6.836.655.75 7.36 6.84 6.190.1900.6030.0930.775L-Serine, ug/mL6.936.426.43 6.76 6.31 6.770.1710.7460.6140.620L-Glutamic acid, ug/mL13.3410.5610.55 9.0812.2011.100.5950.2190.7070.713L-2-Aminoadipic Acid, ug/mL1.792.022.09 1.98 2.21 2.410.1050.6090.6240.826L-Alanine, ug/mL25.0722.0822.7025.4730.4132.340.9510.0010.3950.657L-Citrulline, ug/mL41.6236.4837.8437.6331.9932.721.3340.1520.7460.922DL-2-Aminobutyric acid, ug/mL6.646.446.28 8.75 7.62 7.870.2600.0050.9280.689L-Valine, ug/mL3.664.043.32 3.88 3.62 3.850.1780.9880.6100.336L-Cysteine, ug/mL50.3852.1148.5547.2350.9749.721.2940.7920.4950.743L-Cystathionine, ug/mL2.562.652.42 2.87 2.81 2.970.1130.5800.9120.514L-Isoleucine, ug/mL0.910.640.67 0.75 1.19 2.030.1450.0300.1520.177L-Leucine, ug/mL11.6212.8110.9312.0411.5112.790.3490.9490.7400.089L-Tyrosine, ug/mL21.4621.7919.7223.7322.8722.550.5490.3340.3810.521L-Phenylalanine, ug/mL7.587.877.53 7.39 7.03 8.440.2850.9980.4870.257β-Alanine, ug/mL4.764.304.02 4.96 4.65 4.920.1500.2740.9920.459DL-3-Aminoisobutyric Acid, ug/mL0.240.210.21 0.27 0.35 0.290.0140.0020.2550.2792-Aminoethanol, ug/mL0.040.020.03 0.00 0.05 0.070.0080.1350.5800.811Ammonium Chlodire, ug/mL1.412.102.06 1.29 1.57 1.410.0990.0120.6360.748DL-plus allo-δ-Hydroxylysine, ug/mL2.292.122.19 2.11 2.07 2.250.0270.0710.0460.348L-Ornithine, ug/mL6.297.015.93 6.70 5.87 6.450.2330.9180.6830.183Lysine, ug/mL8.8410.858.38 9.86 8.97 8.980.3470.6300.1590.156L-1-Methylhistidine, ug/mL1.141.821.77 1.66 1.97 2.230.1980.6260.8490.765L-3-Methylhistidine, ug/mL1.221.071.02 1.27 1.29 1.250.0720.6960.8200.977L-Carnosine, ug/mL1.251.461.91 1.18 1.60 2.430.1760.7550.1450.653Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean. Relationship between rumen-protected L-tryptophan (ACT) and blood amino acids (AAs) under heat stress (HS) conditions in dry Holstein cows. Values are expressed as means ± SEM (n = 4). LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean. Experimental (a) design and (b) period. The schematic delineates the experimental design executed within climate chambers, emphasizing heat stress (HS) treatments, specifically low-temperature, low-humidity (LTLH) and high-temperature, high-humidity (HTHH) conditions, supplemented with rumen-protected L-tryptophan (ACT) interventions. Eight early lactating Holstein cows were stratified and subsequently randomized into two groups. In the initial non-HS phase, the cows were subjected to a temperature–humidity index (THI) of 68 over a three-day period. Following this, a designated treatment was administered for four days. Subsequently, a seven-day phase was initiated, during which the cows were exposed to the predefined HS in tandem with ACT administration. After the LTLH treatment was completed, the HTHH treatment was carried out employing a comparable methodology but involving a distinct group of dry Holstein cows. THI: temperature–humidity index. Gene expression in PBMCs The expression levels of heat shock protein (HSP)70 in PBMCs was investigated in dry Holstein cows under HS with ACT supplementation (Fig. 2). In the PBMCs with ACT supplementation, the expression levels of HSP70 increased by 98.97% in the LTLH group and by 100.18% in the HTHH group (P < 0.05).Fig. 2Relative gene expression in the heat shock protein (HSP)70 of peripheral blood mononuclear cell (PBMC) with 30 g rumen-protected L-tryptophan (ACT) in dry Holstein cows. Values are expressed as means ± SE (n = 4). *Means with different superscripts differ significantly according to Tukey’s test (P < 0.05). Relative gene expression in the heat shock protein (HSP)70 of peripheral blood mononuclear cell (PBMC) with 30 g rumen-protected L-tryptophan (ACT) in dry Holstein cows. Values are expressed as means ± SE (n = 4). *Means with different superscripts differ significantly according to Tukey’s test (P < 0.05). Blood hematology Hematological analysis was conducted on blood samples from dry Holstein cows to assess their health status (Table 7). In the blood, only mean platelet volume (MPV) and platelet distribution width cell (PDWc) decreased under HS in the LTLH group by 6.97% and 10.59%, respectively (P < 0.05). However, in the HTHH group, MPV and PDWc increased by 10.14% and 8.60%, respectively (P < 0.05). Conversely, no significant difference was found between the LTLH and HTHH groups following ACT supplementation (P > 0.10, Table 7). There was a significant interaction between HS and ACT for monocytes (P < 0.05) and a tendency for plateletcrit (PCT; P = 0.090).Table 7Relationship between rumen-protected L-tryptophan (ACT) and blood hematology under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTWBC, K/uL 10.00 10.58 12.35 8.88 9.43 8.93 1.0600.9690.3790.514 LYM, K/uL 7.78 7.43 7.16 6.28 5.79 6.11 0.8630.9410.4050.326 MON, K/uL 0.56 0.55 1.25 0.41 0.89 0.19 0.1240.4560.1180.026 GRA, K/uL 1.66 2.60 3.94 2.19 2.75 2.63 0.2580.3130.8340.636RBC, M/uL 7.64 7.00 6.73 7.56 7.28 7.09 0.1460.5380.5840.951 HGB, g/dL 12.90 11.75 11.35 12.43 12.28 11.60 0.2750.6760.3810.987 HCT, % 36.60 32.61 31.11 35.48 34.27 33.37 0.7030.2920.4550.805 MCV, fL 47.75 46.75 46.25 47.25 47.25 47.25 0.3760.7160.6110.611 RDWc, % 19.03 18.85 18.88 19.48 19.20 19.43 0.1310.4790.6370.881 MCH, pg 16.88 16.80 16.90 16.45 16.83 16.35 0.1650.8770.3360.900 MCHC, g/dL 35.20 35.98 36.48 35.00 35.75 34.68 0.2170.1770.2660.273PLT, K/uL332.00306.75244.00328.00241.25308.0018.1200.6830.8770.139 MPV, fL 7.60 8.13 7.73 7.40 8.15 8.53 0.1130.0120.9480.067 PCT, % 0.31 0.25 0.19 0.24 0.20 0.27 0.0160.3610.9590.090 PDWc, % 37.58 33.60 33.50 33.38 36.25 35.95 0.4510.0020.7790.955Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; WBC, white blood cell; LYM, lymphocyte; MON, monocyte; GRA, granulocyte; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; RDWc, red cell distribution width; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; MPV, mean platelet volume; PCT, plateletcrit; PDWc, platelet distribution width. Table 7Relationship between rumen-protected L-tryptophan (ACT) and blood hematology under heat stress (HS) conditions in dry Holstein cows.LTLHHTHHSEMP-valueNon-HSHSHS+ACTNon-HSHSHS+ACTHSACTHS x ACTWBC, K/uL 10.00 10.58 12.35 8.88 9.43 8.93 1.0600.9690.3790.514 LYM, K/uL 7.78 7.43 7.16 6.28 5.79 6.11 0.8630.9410.4050.326 MON, K/uL 0.56 0.55 1.25 0.41 0.89 0.19 0.1240.4560.1180.026 GRA, K/uL 1.66 2.60 3.94 2.19 2.75 2.63 0.2580.3130.8340.636RBC, M/uL 7.64 7.00 6.73 7.56 7.28 7.09 0.1460.5380.5840.951 HGB, g/dL 12.90 11.75 11.35 12.43 12.28 11.60 0.2750.6760.3810.987 HCT, % 36.60 32.61 31.11 35.48 34.27 33.37 0.7030.2920.4550.805 MCV, fL 47.75 46.75 46.25 47.25 47.25 47.25 0.3760.7160.6110.611 RDWc, % 19.03 18.85 18.88 19.48 19.20 19.43 0.1310.4790.6370.881 MCH, pg 16.88 16.80 16.90 16.45 16.83 16.35 0.1650.8770.3360.900 MCHC, g/dL 35.20 35.98 36.48 35.00 35.75 34.68 0.2170.1770.2660.273PLT, K/uL332.00306.75244.00328.00241.25308.0018.1200.6830.8770.139 MPV, fL 7.60 8.13 7.73 7.40 8.15 8.53 0.1130.0120.9480.067 PCT, % 0.31 0.25 0.19 0.24 0.20 0.27 0.0160.3610.9590.090 PDWc, % 37.58 33.60 33.50 33.38 36.25 35.95 0.4510.0020.7790.955Values are expressed as means ± SEM (n = 4).LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; WBC, white blood cell; LYM, lymphocyte; MON, monocyte; GRA, granulocyte; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; RDWc, red cell distribution width; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; MPV, mean platelet volume; PCT, plateletcrit; PDWc, platelet distribution width. Relationship between rumen-protected L-tryptophan (ACT) and blood hematology under heat stress (HS) conditions in dry Holstein cows. Values are expressed as means ± SEM (n = 4). LTLH, low temperature, low humidity; HTHH, high temperature, high humidity; HS, heat stress; ACT, rumen-protected L-tryptophan; SEM, standard error of the mean; WBC, white blood cell; LYM, lymphocyte; MON, monocyte; GRA, granulocyte; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; RDWc, red cell distribution width; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; MPV, mean platelet volume; PCT, plateletcrit; PDWc, platelet distribution width. GC-TOF-MS Even though no significant difference was found in the serum of the HTHH group (P > 0.10; Fig. 3). The HTHH group demonstrated distinct separation and distribution of blood metabolite parameters in the principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) models (R2X = 0.831, R2Y = 1.000, Q2 = 0.884, p = 0.590). In the HTHH group, the PCA analysis of HS/ACT revealed that PC1 (26.7%) exhibited a tendency to distinguish between the same numbers, while PC2 (20.2%) distinguished between HS and ACT. The OPLS-DA analysis further confirmed the distinction of HS/ACT from HS and ACT with OPLS1 (19.4%). In contrast, the HS/ACT PCA analysis did not reveal any significant difference in the LTLH group. Instead, PC1 (26.0%) showed a trend of clustering together with the same numbers.Fig. 3Principal component analysis (PCA) (a, b) and orthogonal partial least squares discriminant analysis (OPLS-DA) (c) score plots for blood serum of dry Holstein cows under low-temperature and low-humidity (LTLH) and high-temperature and high-humidity (HTHH) conditions. Subjects analyzed using GC-TOF-MS. Principal component analysis (PCA) (a, b) and orthogonal partial least squares discriminant analysis (OPLS-DA) (c) score plots for blood serum of dry Holstein cows under low-temperature and low-humidity (LTLH) and high-temperature and high-humidity (HTHH) conditions. Subjects analyzed using GC-TOF-MS. Discussion This study constitutes the first examination of the effects of ACT supplementation on the physiological and metabolic responses of dry Holstein cows in climate-controlled chambers. Previous research demonstrated that supplementation with 30 g/day of ACT in lactating Holstein cows under HS (THI 80 ~ 89) increased DMI by approximately 3 kg13. The increase in DMI with ACT supplementation may reflect the effect of L-tryptophan, a serotonin precursor, shown to stimulate intake in chickens during summer season17. When an additive containing 0.2% of L-tryptophan was provided to a broiler aged 1 to 42 days of age, the stress state, average daily gain, and feed requirement was improved18. L-tryptophan supplementation at 25 and 50 mg/kg body weight mitigated the heat-induced decrease in DMI observed 3 to 4 h post-exposure19. Potentially through hepatic breakdown of ACT into acetate and L-tryptophan, energy and protein utilization efficiency may be enhanced, thereby supporting increased DMI. Given that approximately 95% of ACT bypasses the rumen and is absorbed in the small intestine11, its post-absorptive metabolism in the liver may contribute to improved performance. Moreover, the combined effects of acetate and L-tryptophan may reduce ruminal fermentation while promoting post-ruminal digestion and nutrient absorption13,20. As a gastric and intestinal endocrine hormone, ghrelin is recognized for its potent appetite-stimulating effects across species, including ruminants, and plays a central role in regulating DMI21,22. Previous studies have shown that ghrelin concentrations are suppressed during the summer seasons in dairy cows, suggesting that this reduction may contribute to the observed decrease in DMI22. A study in pigs demonstrated that L-tryptophan supplementation increases ghrelin concentrations and DMI21. Consistent with our findings, ACT supplementation during HS increased ghrelin concentrations, suggesting a potential relationship between ghrelin and the improvement of DMI with ACT. Limited studies have investigated the impact of ACT supplementation on HR, RT, and ST during HS conditions. Three hours of HS was found to reduce the DMI and raise body temperatures significantly in nine-day-old broiler chicks19. As reported by Adeola and Ball23, feeding excess L-tryptophan to pigs for 5 days prior to slaughter results in reduced stress in the pigs, which is attributed to an increased concentration of neurotransmitters in the hypothalamus. The addition of L-tryptophan reduced the RT of broilers exposed to HS and lowered levels of corticotropin-releasing hormone and L-tryptophan 2,3-dioxygenase in serum at a supplementation level of 0.09%24. Our findings, which are consistent with previous research by Sutoh et al.25, demonstrate that supplementing Holstein steers with L-tryptophan at 38.5 mg/kg/2 h can considerably decrease RT and improve stress responses, including intestinal barrier and immune functions, as also indicated in similar studies. The supplementation of serotonin in mammals usually leads to a reduction in body temperature. Along with previous findings, we observed that supplementation with ACT during HS significantly reduced RT and ST. This indicates that ACT may activate heat loss mechanism in dry Holstein cows under HS. Several studies have linked L-tryptophan metabolism to altered microbiomes; the dysregulation of this pathway can affect immune regulation, and overall health8. The L-tryptophan metabolite is converted into several biologically active compounds, including serotonin and kynurenine, that are widely used throughout the body. The supplementation of rumen-protected amino acids is known to affect blood metabolites, with the majority of the influencing factors associated with protein and energy metabolism as well as DMI26. Blood urea nitrogen (BUN) can be used to evaluate protein utilization efficiency, as the excessive or inadequate utilization of amino acids leads to an increase in BUN concentrations. The excess amino acids cannot be stored and are degraded instead, resulting in the production of urea27. In addition, the BUN concentration increases because it does not play a proper role in excretion when there is kidney disease. Elevated body temperature can pose kidney issues, as dehydration can lower blood pressure and decrease kidney function10. Studies have indicated reduced liver enzymes and kidney function in cows during HS28. Blood urea nitrogen (BUN) reflects amino acid utilization efficiency as it increases with urinary nitrogen excretion10. Under metabolic stress, elevated BUN concentrations may result from increased hepatic deamination of amino acids released through skeletal muscle proteolysis29. A reduction in BUN concentration suggests improved nitrogen use efficiency or decreased protein breakdown, which may be influenced by growth hormones or protein synthesis32. This is consistent with previous studies30,31 that have shown a linear decline in BUN concentration with increasing dietary L-tryptophan intake, indicating improved protein utilization in pigs. Under HS, L-tryptophan intake may lower BUN concentrations improving nitrogen use efficiency or reducing protein breakdown due to its antioxidant properties. With the addition of rumen-protected amino acids to the diets used in the study, most of the variables affecting blood metabolites are related to DMI, energy, and protein metabolism; consequently, changes in GLU concentration could be expected due to the increased DMI caused by feeding the animals with various dosages of ACT11,28. Similar to our results, giving L-tryptophan at 50 mg/kg body weight in cattle has been shown to increase blood GLU concentrations32. This suggests that L-tryptophan may affect energy use in the body, possibly by changing gut hormone activity or digestion.These changes may support pancreatic enzyme release and improve digestion, which could explain the rise in GLU seen with L-tryptophan. The findings from both the study with added L-tryptophan and the plasma samples collected during L-tryptophan infusion suggest that each albumin molecule has one binding site for L-tryptophan, and there is an inverse correlation between the binding strength and the concentration of NEFA33. The unchanged NEFA concentrations under HS are consistent with previous findings suggesting limited lipid mobilization despite increased energetic demands7,34,35. The supplementation of ACT leads to an increase in the GLU concentration, which, in turn, promotes efficient energy production and reduces the concentration of NEFA. Despite the lack of significance of biochemical factors (no statistics for cortisol and tendencies in the CHO) in the ACT group with a higher DMI, the low sample size (n = 4) may explain some of the findings. Therefore, larger sample sizes and more frequent sampling may provide new insights into the alterations in blood metabolites. Altered amino acid availability under thermal stress contributes to systemic imbalances indicative of metabolic adaptation36. Furthermore, some free amino acids have been identified as potential biological agents for reducing body temperature under HS36. DL-plus allo-δ-Hydroxylysine, identified as an enzyme and glutamine synthetase inhibitor, experiences reduced levels under HS conditions (33 °C, 60% humidity) in pigs and plays a role in bovine collagen synthesis, potentially affected by HS37,38. Glutamine, an inducer of HSP and protector against endotoxin shock, potentially interacts with L-tryptophan, which crucially facilitates collagen synthesis via nicotinamide adenine dinucleotide phosphate hydrogen production and enhances hydrate formation rates when minimally present (1 wt %), achieving 90% water-to-hydrate conversion within 30 min39. While amino acids participate in the urea cycle, and L-tryptophan and niacin increments seemingly boost collagen synthesis, discerning the specific impacts of L-tryptophan dietary/metabolic factors on DL-plus allo-δ-Hydroxylysine levels, especially under HS in varied species, necessitates further investigation. Phosphoserine is frequently found in proteins due to posttranslational modifications and arises from kinase phosphorylation or incorporation during translation40. The enzyme phosphoserine aminotransferase, which is pyridoxal phosphate (PLP)-dependent, facilitates the conversion between 3-phopsphohydroxy pyruvate and L-phosphoserine, with a conserved L-tryptophan residue stabilizing its active site by interacting with PLP’s pyridine ring41. Phosphoserine degradation produces serine, a glucogenic amino acid involved in gluconeogenesis42. Elevated serine and decreased threonine levels, despite not being statistically significant in our study, imply a potential modulation of gluconeogenesis for energy production. Taurine is integral for multiple biological functions including anti-inflammation, osmoregulation, and immunomodulation, and it offers cytoprotection against free radicals. Essential for mammalian cell function, it promotes immunity and counteracts HS43. Although not linked to protein synthesis or energy, taurine is vital for cell homeostasis and stress mitigation44. Decreased taurine in ACT-treated groups suggests ACT’s potential in alleviating HS-induced effects. Threonine is integral for physiological processes like bone formation, immune regulation, and fat metabolism, and can induce HSP expression, reducing apoptosis in HS intestinal cells, possibly due to osmotic effects45. Jafari et al.46 found decreased threonine in HS-affected poultry, aligning with our results. Liver dysfunction elevates plasma L-tryptophan and reduces amino acids like threonine, affecting its transport to the brain47. The relationship between L-tryptophan and the liver and brain requires further investigation, particularly in light of the observed reduction in threonine levels following ACT supplementation. Cells possess mechanisms to protect against environmental stress12. In animals exposed to temperature and humidity stress, HSP expression may indicate their response. Heat shock protein (HSP) induction improves thermal tolerance by inhibiting stress kinase activation and is associated with survival proteins involved in protein folding, cell wall remodeling, and enzymatic roles affecting cellular structures12. Extensive research on thermal stress in PBMCs identifies HSP induction as a key determinant of thermal tolerance via stress kinase suppression. The study by Choi et al.13 found that supplementing lactating Holstein cows with 30 g of ACT increased the expression of HSP70 in PBMCs, enhancing their stress resistance and non-HS to thermal stress. Additionally, Jo et al.12 reported that the supplementation of 30 g ACT to early lactating Holstein cows in a metabolic chamber increased HSP70 gene expression in PBMCs. Recent research has suggested that L-tryptophan, nicotinic acid, and nicotinamide metabolites may induce mitochondrial stress and increased expression of HSP through endoplasmic reticulum stress and unfolded protein responses48. During HS exposure, serotonin has the ability to activate heat shock factor 1, which acts as a transcriptional activator of HSPs. This activation plays a crucial role in preventing protein aggregation and ensuring proper protein folding48. However, the precise mechanism underlying the effect of ACT on HSP expression in PBMCs remains unknown and needs further investigation. This study demonstrated that the supplementation of ACT (30 g/day) to dry Holstein cows exposed to HS conditions potentially improved various parameters, including DMI, physiological indicators (rectal and skin temperature), metabolites (BUN, GLU, NEFA, CHO, and ghrelin), free amino acids (DL-plus allo-δ-Hydroxylysine, o-phosphoserine, taurine, and L-threonine). The study also showed a correlation between the interaction of various amino acids due to L-tryptophan addition and mechanisms related to energy and immunity. Based on the findings, ACT supplementation shows potential for mitigating HS in dry Holstein cows. However, the limited sample size, although consistent with prior literature, constrains the precision of estimates and the generalizability of outcomes. To strengthen the evidence base, future large-scale trials are needed to validate these results and assess subgroup variability. In addition, further research should evaluate the effects of ACT supplementation on lactating cows and their offsprings after parturition, particularly under HS conditions and across diverse environmental conditions. Materials and methods Animal care and housing This study followed the ARRIVE guidelines, ensuring compliance with relevant regulations. All animal procedures were conducted according to Konkuk University`s Animal Experimental Guidelines and were approved by its Institutional Animal Care and Use Committee (IACUC), Republic of Korea (Approval No: KU19124). The dry Holstein cows used in this study were housed and managed at Konkuk University`s experimental farm. Experimental design and animals This study utilized eight dry Holstein cows that were selected based on their similar dried-off period of 60 days before the expected calving date (46 ± 2 days), body weight (550 ± 9 kg) and parity (2.63 ± 0.27) out of the thirty multiparous dry Holstein cows. Each of the eight cows was assigned to a specific temperature and humidity chamber six weeks before parturition in consideration of the stress of non-lactation. The limited availability of four chambers, each measuring 3 m × 4 m × 5 m (length x width x height), restricted the ability to conduct two sets of THI levels simultaneously, as each temperature and humidity condition required four cows per period. Studies including12 demonstrate that four cows per group are adequate for statistical and experimental validity as supported by similar research using comparable sample sizes11,16,49,50 Chamber-based experiments particularly those assessing diverse physiological responses are inherently limited by the number of cows they can accommodate. Chamber experiments, which focus on various physiological phenomena, differ from other types of experiments in their limitation on the number of cows used. Prior to the commencement of the experiment, the dry Holstein cows underwent training and acclimatization within controlled-climate chambers. The experimental protocol entailed the feeding and management of the cows within these chambers for approximately 5 h daily, over a period of three days in a week. In the experiment, each dry Holstein cow was placed into a single chamber. A video camera system was installed within the chamber to facilitate real-time monitoring of the dry Holstein cow’s health status. Moreover, to minimize the impact of heat production due to feces and urine, these were removed on the same day they were produced. Access to the chamber was restricted, except for the provision of feed and water, to minimize the loss of temperature and humidity. To ensure air circulation within the chamber, identical ventilators were installed. The temperature and humidity were adjusted for 3 days during the adaptation phase (non-HS) to ensure the environment in each chamber was suitable for the cows. After the non-HS phase, the calves and cows were exposed to 4 days of HS50–53 Following the HS phase, the cows were fed a basal diet supplemented with an additional 30 g of ACT (CJ CheilJedang, Suwon, Korea) for 7 days (Fig. 1)12. Prolonged exposure to HS for 3 to 5 days or more leads to a significant and gradual reduction in productivity. For this reason, to evaluate the rapid response of ACT in reducing the physiological and metabolic disruptions caused by HS, a 7-day assessment period was determined to be optimal for this study. The data from the corporation indicated a bypass rate above 95%. N-acetyl-L-ACT (CJ CheilJedang, Seoul, South Korea), an ACT derivative produced via chemical modification of an α-amino group with an acetyl group, was utilized as the source of ACT. N-acetyl-L-tryptophan is metabolically equivalent to free L-tryptophan and acetic acid. Digestion in the small intestine (enzymatic reaction): N-acetyl-L-tryptophan + H2O → (hydrolysis by acylase I) → L-tryptophan + acetic acid. Presented in powder form the ACT product exhibited an L-tryptophan concentration of 83.0% with a purity level of 99.5%. The experimental diets were provided twice daily (0800 h and 1400 h) according to the NRC nutrient requirement54 (Table 1). Table 1 presents a summary of the basal diet and amino acid compositions. Fresh water was provided for the dry Holstein cows five times daily. During the ACT feeding phase under HS, the daily ACT allocation, which consisted of 30 g of ACT/animal of DMI for cows (0.15%), was top-dressed onto the straw and concentrate. Temperature–humidity index The experiment was conducted in a temperature- and humidity-controlled automatic chamber system, where the ambient temperature was fixed at 25 °C (low temperature, LT) and 31 °C (high temperature, HT), and the RH was classified into two levels: 35% (low humidity, LH) and 80% (high humidity, HH). From 0900 to 1900 h, the dr Holstein cows were subjected to the designated HS temperature and RH levels with the lights turned on, considering the 12-h photoperiod in Korea12. From 1900 to 0900 h the next day, exposure continued under normal temperature and RH conditions with the lights turned off. For the recording of environmental data, two thermos-hygrometer data loggers, MHT-318SD, with an accuracy of ± 4% on the RH and ± 0.8 °C on the temperature (Tdb), were positioned inside the chamber at the front and back for consistent maintenance. Within the chamber, an automated environmental control system was implemented to consistently regulate temperature and humidity, ensuring the maintenance of predetermined set points. The temperature–humidity index (THI) formula used in this study was based on the equation by Jo et al.16: (1.8 × Tdb + 32) − [(0.55 − 0.0055 × RH) × (1.8 × Tdb − 26)], where Tdb represents the dry bulb temperature (°C) and RH represents the relative humidity (%). The temperature and humidity were controlled through an air conditioner (CSVR-Q118E, Carrier, South Korea) and a humidifier (DE-9090UH, Zhongshan Xinhao Electrical., LTD) and dehumidifier (EDHA11W3, WINIA), respectively. Sampling and analysis Feed and water intake The dry Holstein cows in each group were provided with feed twice a day (0830 h and 1400 h) and water five times a day, in accordance with their requirements. The DMI and water intake (WI) was calculated by measuring the amount of feed and water newly provided at 0830 h and the leftovers the next morning at 0800 h, excluding the weight of the large trough, using a scale (GL-6000S Series, G-Tech International, South Korea). The water was consistently maintained at a temperature of 15 °C, which is the usual drinking temperature for cows. Samples of straw and concentrate were collected on a weekly basis, underwent dry matter (DM) analysis after being dried for three days at 65 °C in a forced-air oven, adhering to the AOAC55 protocol. Subsequently, these ground experimental diets were evaluated to determine their estimated contents of DM, crude protein (CP), crude ash (CA), crude fat (CF), among others. The content of CA was precisely quantified through high-temperature incineration in a muffle furnace (KMF-500, Lab Corporation, South Korea) at 550 °C overnight, strictly adhering to the standardized protocol outlined in AOAC 942.05 to ensure methodological accuracy and reproducibility. In preparation for analysis, samples were preserved at − 20 °C. The nitrogen content in the feed was quantified using an automatic distiller Kjeldahl (Kjeltec 8400 Analyzer, Hillerød, Denmark), as specified by AOAC55, with CP values derived by applying a conversion factor of 6.25. The extraction of crude fat was performed using an Ankom XT15 extractor (Ankom Technology Corp, NY, USA), following the procedure outlined in AOAC 920.39. The analysis of neutral detergent fiber (NDF) and acid detergent fiber (ADF) followed the methods described by Van Soest et al.56, using an Ankom 200 fiber analyzer (Ankom Technology Corp., NY, USA). NDF analysis included the use of heat-stable α-amylase. Nonfibrous carbohydrate (NFC), truly digestible nonfibrous carbohydrate (tdNFC), truly digestible crude protein (tdCP), and truly digestible fatty acid (tdFA) were calculated in alignment with the guidelines set by the NRC54. Physiological indicators During exposure to the temperature and RH environment in metabolic chambers, changes in physiological indicators including HR (bpm/min), ST (°C), and RT (°C) were measured. Measurements were taken at 0900 h and 1400 h on the 3rd day (non-HS), 7th day (HS), and 14th day (HS with ACT supplementation) from the experiment group. Heart rate (HR) was assessed by counting beats per minute using a stethoscope. Skin temperature (ST) was measured using an S60 machine (Caterpillar FLIR camera, Wilsonville, USA) to measure the temperature of the hook, wither, and udder. Rectal temperature (RT) was measured by inserting a plunge probe thermometer (TES 1300, K Type thermometer, Taipei, Taiwan) into the rectum of the cow and holding it for one minute. Blood profiles Blood samples were collected from the bovine jugular vein at 1400 h on the 3rd day (non-HS), 7th day (HS), and 14th day (HS with ACT supplementation) for each group of experiments. To minimize blood data variability, feeding was restricted for 4 h before blood collection at 1400 h. Blood samples were collected via jugular venipuncture into EDTA-treated vacutainers (Becton–Dickinson, NJ, USA) for hematological analysis, which was performed within 12 h using the VetScan HM2 hematology system (Abaxix, Tampa, USA). Serum samples were collected in non-heparinized vacutainers (BD Vacutainer, Plymouth, UK) and analyzed for blood metabolites using a chemical analyzer (Model 7180, Hitachi, South Korea). Plasma from heparinized vacutainers (Becton–Dickinson, Plymouth, UK) was used to measure cortisol, haptoglobin, and ghrelin concentrations using ELISA kits (CSB-E13064B, CUSABIO, Houston, USA, MBS739905, MyBioSource, San Diego, USA, and EB0066, FineTest, Hubei, China, respectively), with absorbance read at 450 nm using a spectrophotometer (PMT49984, BioTek Instruments Ltd, Winooski, USA). The intra- and inter-assay coefficients of variation were 10% and 8% for cortisol, 8% and 10% for hapoglobin, and 5.12% and 4.25% for ghrelin, respectively. The serum and plasma samples from blood were aliquoted into 1.5 mL tubes (Eppendorf AG, Hamburg, Germany) and stored in a − 80 °C deep freezer (U9280-0002, New Brunswick, Canada) until analysis. Free amino acid measurement The methodology for quantifying free amino acids in plasma was conducted in accordance with the protocol established by Reverter et al.57. Briefly, to precipitate proteins, 500 μL of plasma was mixed in a 1:1 ratio with a solution of 5-trichloroacetic acid, prepared by dissolving 3 g of the reagent in 10 mL of distilled water. Following centrifugation at 25,200 × g for 5 min, the resultant supernatant was passed through a 0.25 µm filter. The filtrate was then collected in a vial for subsequent analysis. This analysis involved ion-exchange chromatography coupled with post-column ninhydrin derivatization, employing a Hitachi L-8900 amino acid analyzer (Hitachi High Technologies, Tokyo, Japan). Quantification was performed using authentic standards (Wako, Japan) and EZChrom Elite version 3.1.5b software58. Peripheral blood mononuclear cells isolation To evaluate PBMC expression, blood samples were collected in heparin tubes (Becton–Dickinson, Plymouth, UK) and maintained at room temperature. A 15 mL tube was prepared by combining 3 mL of blood with 3 mL of histopaque-1077 reagent (RNBF8871, Sigma-Aldrich Co. LLC, Saint Louis, MI, USA). The tube was centrifuged at 400 × g for 30 min at 20 °C, resulting in a 2 mL buffy coat layer. This layer was transferred into a 15 mL tube containing 8 mL of PBS (P2004, Biosesang, Korea) and centrifuged again at 300 × g for 10 min at 20 °C. The resulting pellet was resuspended in 1 mL of TRIzol reagent (TR 118, Molecular Research Center, USA) within a 2 mL tube to ensure proper solubilization. Measuring mRNA expression in peripheral blood mononuclear cell The study utilized the TRIzol extraction method for total RNA extraction in the laboratory12. The RNA concentration was determined using a spectrophotometer (NanoDrop 1000, Thermo Scientific, Seoul, Korea) with the RNA-40 module, while the RNA integrity number (RIN) was measured using the RNA Nano 6000 Assay kit on an Agilent 2100 Bioanalyzer (Agilent, Richardson, USA) to ensure an RIN of 6.5 or higher. cDNA synthesis was carried out using the iScript cDNA synthesis kit (Bio-Rad, Seoul, Republic of Korea). Reverse transcription was performed in a 20 uL reaction mixture containing 1 ug of total RNA, 4 uL of 5 × iScript reaction mix, 1 uL of iScript reverse transcriptase, and nuclease-free water. The reaction was carried out on a T100 Thermal Cycler (Bio-Rad, Seoul, Republic of Korea) under the following conditions: 5 min at 25 °C for priming, 30 min at 42 °C for reverse transcription, and 5 min at 85 °C for inactivation. After synthesis, the cDNA was diluted to 200 ng/uL with DEPC-treated water and stored at − 20 oC until qPCR. For qPCR, the reaction mixture (20 uL) included 10 uL of SYBR Green qPCR Master Mix (AccuPower 2 Green Star qPCR MasterMix, Bioner, Seoul, Republic of Korea), 0.6 uL each of forward and reverse primers (10 uM), 2.5 uL of cDNA, and 6.3 uL of DEPC-treated water. qPCR was performed on a CFX Connect Real-Time PCR Detection System (Bio-Rad, Seoul, Republic of Korea) using the following conditions: initial denaturation at 95 °C for 3 min, followed by 39 cycles of 10 s at 95 °C, 30 s at the gene-specific annealing temperature, and 30 s at 72 °C, followed by plate reading. Melting curve analysis was performed from 65 to 95 °C with 0.5 °C increments for 5 s, followed by final plate reading. Amplification efficiencies were calculated from a standard curve using tenfold serial dilutions, with all genes showing efficiencies above 95%. Relative gene expression was normalized to the reference genes glyceraldehyde-3-phosphate dehydrogenase, beta-2-macroglobulin, and ribosomal protein S15a for PBMC59, and data analysis was conducted using the 2 − ΔΔrCT method in CFX Maestro 1.0 software (Bio-Rad, Seoul, Republic of Korea). Table 2 lists the primer sequences employed for qPCR analysis. Expression stability of the reference gene was verified by confirming that its coefficient of variation remained below 5% prior to analysis. These sequences were designed using the online system of the National Center for Biotechnology Information (NCBI) and procured from Bioneer Co. (Bioneer, Seoul, Republic of Korea). Extraction of serum sample and GC-TOF-MS analysis All procedures for the measurements followed the procedure previously described by Jung et al.60. Standard compounds were obtained from Sigma-Aldrich (St. Louis, MO, USA). Briefly, after extracting serum samples from the blood, 150 µL of serum was mixed with 450 µL of cold methanol in a 1:3 ratio. The mixture was homogenized for 10 min using a mixer mill machine (Retsch GmbH & Co, Haan, Germany) at a frequency of 30 s−1 and stored at − 20 °C for 1 h. After centrifugation at 19,000 × g for 10 min at 4 °C, the supernatant was carefully passed through a 0.2 µm PTFE membrane filter to remove particulate matter and subsequently aliquoted into Eppendorf tubes under controlled conditions to preserve sample integrity. Following complete evaporation of the supernatant using a speed vacuum concentrator, the dried serum sample was dissolved in methanol, filtered through a 0.2 µm syringe filter, and analyzed by gas chromatography-time of flight-mass spectrometry (GC-TOF-MS). The operation of the GC-TOF-MS system in this study followed the protocol outlined by Jung et al.60, utilizing an Agilent 7890B GC system (Agilent Technologies, Palo Alto, USA) in conjunction with a Leco TOF Pegasus BT mass spectrometer (LECO, St. Joseph, MI, USA). Statistical analysis Statistical analyses were performed using SAS (Studio Version, SAS Institute Inc., Cary, NC) with the mixed procedure for repeated measure analysis. The repeatedly measured properties, including DMI and WI, were analyzed using a random effect in the model for animal distribution into treatment. The model encompassed factors such as HS, ACT, and the interaction between HS and ACT. Multiple comparisons within the model were not adjusted. The employed model for repeated measures was formulated as follows: Yijk = µ + αi + γ(α)ijk + εijk. In this model, Yijk denotes the observation of dry Holstein cows k at sampling day j for a specific treatment i; µ is the overall mean; αi represents the fixed effect of treatment i (non-HS, HS, and ACT groups); γ(α)ijk indicates the random effect of dry Holstein cows k nested within treatment i and sampling day j (daily); εijk is the residual effect. To determine the best-fit model, various variance and covariance structures, including autoregressive order 1, unstructured covariance, compound symmetry, and variance components, were evaluated. The selection of the covariance structure was based on the lowest Akaike Information Criterion (AIC) values, ensuring alignment with the experimental design61. The physiological indicators and blood parameters such as metabolites, free amino acids, and hematology were analyzed using two-way analysis of variance. The two-way analysis utilized the following model: Yijk = μ + αi + βj + γij + εijk, where Yijk is the measurement for dry Holstein cows k at sampling day (3rd and 7th) j under treatment i; μ stands for the overall mean; αi indicates the effect of HS; βj denotes the effect of ACT; γij describes the interaction between HS and ACT; εijk is the residual effect, reflecting the variance not explained by the model factors. To determine the significance of variance among the LSmeans of the studied parameters, Tukey’s honest significant difference test was employed. Additionally, the expression of HSP family genes in the PBMCs was analyzed using a t-test. The t-test was conducted using the model: Yik = µ + βi + εik, wherein Yik signifies the data collected from dry Holstein cows k subjected to treatment i; µ represents the aggregate mean; βi is the fixed effect associated with treatment i (HS and ACT groups); and εik constitutes the residual effect. Initial analysis revealed no significant differences in the initial DMI, WI, physiological indicators, blood parameters (hematology, metabolite, and free amino acid), and gene expression in PBMCs among non-HS, HS, and ACT groups. A significant level of P < 0.05 was indicated as statistically significant, while values ranging from 0.05 to 0.10 were considered indicative of a significant trend tendency. The standard error of the mean was reported. Metabolomics data pre-processing and statistical analysis were performed based on the protocol suggested by Jung et al.60. To summarize, the raw data obtained from GC-TOF-MS were transformed into common data format (CDF) files, specifically network CDF, through the application of LECO ChromaTOF software (version 4.44, LECO Corporation) on July 3, 2020. Alignment and retention time correction were performed using the METALIGN program (accessed on 29 August 2022), and the resulting data were then converted into an Excel file. A three-dimensional matrix was created using information on peaks, peak areas, and sample names. Multivariate statistical analysis was conducted using the SIMCA-P + software program (Umetrics, Sweden, accessed on 30 August 2022), starting with unsupervised PCA to explore the overall trends among all groups. A supervised OPLS-DA model was implemented to discern significant metabolomic differences between groups, guided by variable importance in projection (VIP) values.